These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 9711972)
1. Second International Symposium on the Treatment of Parkinson's Disease. Mizuno Y Neurology; 1998 Aug; 51(2 Suppl 2):S1. PubMed ID: 9711972 [No Abstract] [Full Text] [Related]
2. Research update on Parkinson's disease and other movement disorders: highlights from the Eighteenth Annual Symposium on the Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Other Movement Disorders, October 3, 2004, Toronto, Ontario, Canada. Weiner WJ Rev Neurol Dis; 2005; 2(1):27-9. PubMed ID: 16400301 [No Abstract] [Full Text] [Related]
3. Parkinson's disease. An overview of treatments and research. Tuite PJ Minn Med; 2001 May; 84(5):42-7. PubMed ID: 11398632 [No Abstract] [Full Text] [Related]
4. Drugs for Parkinson's disease. Med Lett Drugs Ther; 2017 Nov; 59(1534):187-194. PubMed ID: 29136401 [No Abstract] [Full Text] [Related]
5. Parkinson's disease. Clarke C; Moore AP Clin Evid; 2002 Jun; (7):1208-20. PubMed ID: 12230738 [No Abstract] [Full Text] [Related]
6. Comparison table: drugs for Parkinson's disease. Med Lett Drugs Ther; 2017 Nov; 59(1534):e194-e196. PubMed ID: 29136402 [No Abstract] [Full Text] [Related]
7. Off and on state assessment of swallowing function in Parkinson's disease. Warnecke T; Hamacher C; Oelenberg S; Dziewas R Parkinsonism Relat Disord; 2014 Sep; 20(9):1033-4. PubMed ID: 24997546 [No Abstract] [Full Text] [Related]
8. Future strategies for the treatment of Parkinson's disease. Fahn S Adv Neurol; 1993; 60():636-40. PubMed ID: 8420202 [No Abstract] [Full Text] [Related]
9. Early, nondisabling Parkinson's disease: weighing the options for initial therapy. Silver DE Neurol Clin; 2008 Aug; 26(3 Suppl):S1-13, v. PubMed ID: 18774439 [TBL] [Abstract][Full Text] [Related]
10. Researchers unite to improve Parkinson's drug discovery. Dolgin E Nat Med; 2010 Mar; 16(3):247. PubMed ID: 20208492 [No Abstract] [Full Text] [Related]
12. Parkinson's disease. Clarke C; Moore A Clin Evid; 2002 Dec; (8):1370-85. PubMed ID: 12603943 [No Abstract] [Full Text] [Related]
13. [Parkinson's diseases: power of search]. Agid Y Rev Neurol (Paris); 2010 Oct; 166(10):755. PubMed ID: 20801469 [No Abstract] [Full Text] [Related]
14. Parkinson's focus. Parkinson's is debilitating but new treatments are on the horizon. Hermanns M RN; 2008 Oct; 71(10):24-8; quiz 29. PubMed ID: 18942321 [No Abstract] [Full Text] [Related]
15. Safinamide (Xadago) for Parkinson's disease. Med Lett Drugs Ther; 2017 Sep; 59(1529):151-153. PubMed ID: 28880847 [No Abstract] [Full Text] [Related]
17. [Parkinson's disease: advances in the decade of the brain]. Tolosa E; Chacón J Arch Neurobiol (Madr); 1991; 54(6):261-3. PubMed ID: 1811456 [No Abstract] [Full Text] [Related]
18. Parkinson's disease: an enigma: highlights from the 8th International Congress of Parkinson's Disease and Movement Disorders, June 13-17, 2004, Rome, Italy. Weiner WJ Rev Neurol Dis; 2005; 2(1):20-2. PubMed ID: 16400299 [No Abstract] [Full Text] [Related]
19. [Tolcapone treatment of late stages of Parkinson's disease]. Fedorova NV; Chigir' IP; Krivonos OV Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(6):31-4. PubMed ID: 15984185 [No Abstract] [Full Text] [Related]